pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

10,027 catalysts · 3,152 8k filing · 2,091 grant · 1,128 approval · 1,000 device adverse event · 848 device 510k · 610 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 45 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-08×clear all
type
  • 8k filing3,152
  • grant2,091
  • approval1,128
  • device adverse event1,000
  • device 510k848
  • device pma610
earnings
584
  • device recall318
  • recall215
  • phase 2 completion172
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Jan 19, 2026

    50
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)GlaxoSmithKline LLC

    EXCEDRIN 2'S DISP.- 30 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Aphios Corp

    Toothpaste: a) COLGATE, TOOTHPASTE, WHITENING, 2.5oz, 24ct; UPC: 035000511065; b) COLGATE, TOOTHPASTE, Regular, 2.5oz, 24ct, UPC: 035000511058; c) COLGATE, TOOTHPASTE, TRIPLE, 2.5oz, 24ct, UPC: 035000512109; d) COLGATE, TOOTHPASTE, MINT ZING, 24CT, 2.5oz, UPC: 035000744609; COLGATE, MAXFRESH, SPICY FRESH, RED TOOTH PASTE, 72CT, 150G; e) CREST, TOOTHPASTE, 40CT, 8.2OZ, UPC: 037000247081 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Fluocinolone Acetonide Solution Topical Solution USP, 0.01%, 60-mL bottles, Rx only, Dist. by: Taro Pharmaceuticals Inc., Hawthorn, NY 10532. NDC 51672-1365-4 — Reason: Failed Impurities/Degradation Specifications: Out of specification result was obtained for the known impurity D. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Viatris Inc

    Deodorant: a) Axe, Body Spray, Wild Spice, 6CT, 150ML, UPC: 600108736469; b) LUCKY MENS STICK DEODORANT, SPRING FRESH, 24CT, 2.5 OZ, UPC: 808829111668; c) LUCKY MENS STICK DEODORANT, FRESH COMFORT, 24CT, 1.6 OZ, UPC: 808829089103; d) LADY DEODORANT, CHERRY BLOSSOSM, 24CT, 1.8oz, UPC: 048155921092; e) AXE, BODY SPRAY, APOLLO, 6CT, 150ML; f) AXE, BODY SPRAY, BLACK, 6CT, 150ML; g) AXE, BODY SPRAY, DARK TEMPTATION, 6CT, 150ML; h) AXE, BODY SPRAY, GOLD, 6CT, 150ML; i) AXE, BODY SPRAY, EXCITE, 6CT, 150ML; j) AXE, BODY SPRAY, ICE CHILL, 6CT, 150ML; k) AXE, BODY SPRAY, MUSK, 6CT, 150ML; l) AXE, DEODORANT SPRAY, ADRENALIN, 6CT, 150ML — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    CHILDREN NYQUIL, COLD&FLU, BERRY, 8oz, 12ct — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Halls Cough Drops a) BAGS, MENTHOL, 12CT; b) BAGS, HONEY LEM, 12CT; c) BAGS, DEFENSE CITRUS, 12CT; d) BAGS, CHERRY, 12CT; e) M. CHERRY, 20 STK; f) BRAZIL, Cherry, 21CT/27.5G; f) LEMON. HONEY, 20CT #1180E; g) LIME FRESH, 20CT, #1182; h) MENTHOL BLUE, 20CT, #1180A; i) BRAZIL, Menthol, 21CT/27.5G, j) M . STRAWBERRY, 20 STK; k) DEFENSE, VITAMIN C, 20CT, #1181 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Kenvue Inc.

    Advil a) Ibuprofen, Dispenser Pack, 2 tablet packets in box containing 50 individual packets, UPC: 305730154895; b) PM, Ibuprofen, Dispenser Pack, 2 Caplet packets in box containing 50 packets, UPC: 305730164559 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    PEPTO BISMOL 32CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Carmex a) jar, 12 count, UPC: 083078123154, 083078113155; b) Tube, PEG, 12 count, UPC: 083078123147, 083078113148 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoEncon Safety Products Co recall (Cls II)

    AQ 120 GFEW, Aquarion Preserved Cartridges (2) 3.7 Gallons each — Reason: cGMP deviations. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    LIQUID NYQUIL a) regular, 12/8oz; b) cherry, 12/8oz — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoCipla USA, Inc. recall (Cls II)Cipla USA Inc

    Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059. NDC: 69097-870-67 — Reason: Presence of Particulate Matter. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    NYQUIL COLD & FLU -32CT/2PK — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Claritin, 20 Count, UPC: 655708016305 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoAdvanced Pharmaceutical Technology, Inc. recall (Cls II)Transdermal Delivery Solutions Corp

    TESTO-100 CIII (testosterone 100 mg), 10 Sterile Pellets per carton, Rx only, Manufactured by: Advanced Pharmaceutical Technology, 132 South Central Avenue, Elmsford, NY 10523, NDC# 57377-100-01 — Reason: Lack of Assurance of Sterility: Potential microbial contamination of subcutaneous pellets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoAlvogen, Inc recall (Cls II)Alvogen Inc

    Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Shenandoah, IA, 51601 USA, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058 USA, NDC: 47781-662-10. — Reason: Product Mix-Up: A single bottle of this lot was reported by a pharmacy to contain 88 mcg tablets instead of 150 mcg tablets. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Bayer 2Pk- 25 CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)Kenvue Inc.

    PEPCID COMPLETE - 25CT — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    DAYQUIL COLD & FLU, 32CT/2PK — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Alka Seltzer, a) Original, 2 tablets per packet in 58 count box, UPC: 815556020033, 016500514473, b) Plus Cold & Flu, 2 tablets per packet in 36 count box, UPC: 016500594932 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoGOLD STAR DISTRIBUTION INC recall (Cls II)

    Benadryl, 25'S 2PK Box, UPC 815556020316 — Reason: CGMP Deviations: Insanitary conditions including rodent exposure/activity in their distribution center. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026recall204d agoSUN PHARMACEUTICAL INDUSTRIES INC recall (Cls III)TEVA PHARMACEUTICAL INDUSTRIES LTD

    Clindamycin Phosphate USP, 1% (10 mg/mL), Topical Solution, 60 mL per applicator bottle, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel; Dist. by: Taro Pharmaceuticals USA, Inc., Hawthorne, NY 10532, NDC# 51672-4081-4 — Reason: Failed Impurities/Degradation: Out of Specification results for Total Impurities and for Assay. — Status: Ongoing

    full page →fda recalls ↗
    ›Jan 21, 2026device 510k204d agoVerge Medical, Inc. — RoVo Mechanical Thrombectomy System (510k cleared)VYCOR MEDICAL INC

    Product code: QEW. Advisory committee: Cardiovascular. Type: Special

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoNova Biomedical Corporation — Nova Max Creat eGFR Monitoring System (510k cleared)

    Product code: SHB. Advisory committee: Clinical Chemistry. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoArthrex, Inc. — Arthrex Variable Angle (VA) Proximal Tibia Plating System (510k cleared)

    Product code: HRS. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoBoston Aesthetics, Inc. — Boston Pico755 (510k cleared)

    Product code: GEX. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoDigital Surgery Systems, Inc. (D.B.A True Digital Surgery) — Affirm 400 (510k cleared)

    Product code: QFX. Advisory committee: Neurology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoMerit Medical Ireland, Ltd. — InQwire Super Stiff Guide Wire (IQSS32180J3); InQwire Super Stiff Guide Wire (IQSS35F260S); InQwire Super Stiff Guide Wire (IQSS35F150S); InQwire Super Stiff Guide Wire (IQSS35F100S); InQwire Super Stiff Guide Wire (IQSS35F80S); InQwire Super Stiff Guide Wire (IQSS35F180S) (510k cleared)

    Product code: DQX. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoVarian Medical Systems, Inc. — Halcyon, Ethos Radiotherapy System (5.0) (510k cleared)MERIT MEDICAL SYSTEMS INC

    Product code: IYE. Advisory committee: Radiology. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoMedtronic Sofamor Danek USA, Inc. — Infinity™ OCT System (510k cleared)Medtronic USA Inc

    Product code: NKG. Advisory committee: Orthopedic. Type: Special

    full page →fda device 510k ↗
    ›Jan 21, 2026device 510k204d agoHangzhou SHINING3D Dental Technology Co., Ltd. — LumiCera (510k cleared)

    Product code: EBF. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Jan 21, 2026device pma204d agoTusker Medical, Inc. — Tula Tube Delivery System (TDS) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: QJA. Advisory committee: EN. Decision: OK30

    full page →fda device pma ↗
    ›Jan 21, 2026device pma204d agoBoston Scientific Corp — Precision Spinal Cord Stimulator (SCS) Systems (PMA supplement)BOSTON SCIENTIFIC CORP

    Supplement type: Normal 180 Day Track. Product code: LGW. Advisory committee: NE. Decision: APPR

    full page →fda device pma ↗
    ›Jan 21, 2026device recall204d agoAuris Health, Inc device recall (Cls II)

    MONARCH Platform, Bronchoscopy, Catalog Numbers: MON-000005-01 , MON-000005-01R , MON-000006 , MON-000006-RFB, MON-000008 with software — Reason: Device for bronchoscopic visualization, patient airway access has software issue: if application restarts after patient-side selection, prior to bronchoscope loading, application will re-initialize to patient-left position; and if right position was previously selected, this may lead to unanticipated robotic arm positioning toward patient-left, may result in contact with patient/endotracheal tube. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 21, 2026device recall204d agoStaar Surgical AG device recall (Cls II)STAAR SURGICAL CO

    EVO+ Visian Toric Implantable Collamer Lens (TICL), Model: VTICM5 — Reason: Toric Implantable Collamer for correction/reduction of myopia in phakic eyes with astigmatism were labeled as 12.1 mm length but are 12.6 mm length lenses, so there is the potential for excessive vault, which may cause: Significant reduction of irido-corneal angles, Significant shallowing of anterior chamber, Patient discomfort, Elevated IOP/Angle closure, Unreactive pupil, Lens exchange/removal. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 21, 2026device recall204d agoPhysio-Control, Inc. device recall (Cls II)

    PHYSIO CONTROL INFANT/CHILD Reduced Energy Defibrillator Electrodes Catalog Numbers: 11101-000016 UDI-DI code: 00721902629013 Catalog Number: 11101-000017 UDI-DI code: 00721902682483 Infant/Child Reduced Energy Defibrillation Electrodes are pre gelled, self-adhesive, therapy electrodes that allow hands free defibrillation. These electrodes reduce the energy delivered to the patient by a factor of 4:1. The Infant/child reduced energy defibrillation electrodes are therapy electrodes designed to allow personnel who are trained on AED device operation and in basic life support, or other physician authorized emergency medical response systems, to safely and effectively defibrillate infants and children who are less than 8 years old or weigh less than 25kg (55lbs). — Reason: Due to pediatric defibrillator electrode delamination — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 21, 2026device recall204d agoStryker Corporation device recall (Cls II)STRYKER CORP

    MOLLI 2 System System includes: MM1000 (Pack of 10) - MOLLI Introducer (8cm, 14G) and MOLLI Marker UDI (GTIN): 00850024195028 MS-00009 (Pack of 10) - MOLLI Introducer (12cm, 14G) and MOLLI Marker UDI (GTIN): 00850024195134 MP2001 - MOLLI 2 Wand UDI (GTIN): 00850024195141 MP2015A - MOLLI OncoPen UDI (GTIN): 00850024195219 MT2001 - MOLLI 2 Tablet UDI (GTIN): 00850024195158 The MOLLI Marker is intended to be placed percutaneously in soft tissue to temporarily mark a surgical site intended for surgical removal. the MOLLI Marker is located and surgically removed with the target tissue. — Reason: Due to a need to update the product labeling (Instructions for Use IFU) as a result of the magnetized surgical tools dislodging markers using during target tissue removal procedures. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 21, 2026device recall204d agoAgiliti Health - Ellis device recall (Cls II)

    Adapt Pump, Model/Catalog Number: 61600200-Adapt Pump, component of Adapt support surfaces (Adapt Air, Adapt Air EX, Adapt Air Pro, Adapt Air Pro EX, Adapt Convertible, Adapt Convertible EX), sofware version 1.3.0; Mattress, Air Flotation, Alternating Pressure — Reason: Agiliti identified an issue where the Adapt Pump (61600200-Adapt Pump) supplied with all Adapt Line support surfaces does not re-engage the Microclimate Management function after using the Autofirm function for 10 minutes. This issue only occurs when the 10-minute timer is allowed to elapse after the Autofirm button is pressed after initial setup, and it only affects the Microclimate Management function. — Status: Ongoing

    full page →fda device recalls ↗
    ›Jan 21, 2026grant204d agoKEYSTONE SYMPOSIA — Cardiometabolism in Health and Disease

    HL grant. $18,100. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Jan 22, 2026approval203d agoATORVASTATIN CALCIUM — FDA approvalSciegen Pharmaceuticals Inc

    Sponsor: SCIEGEN PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 22, 2026approval203d agoKETOROLAC TROMETHAMINE — FDA approvalKetorolac Tromethamine Apotex

    Sponsor: APOTEX. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Ketorolac Tromethamine Apotex →fda approvals ↗
    ›Jan 22, 2026approval203d agoOLANZAPINE — FDA approvalolanzapine ODT

    Sponsor: CADILA PHARMS LTD. Form: TABLET. Route: ORAL

    full page →olanzapine ODT →fda approvals ↗
    ›Jan 22, 2026approval203d agoOXAPROZIN — FDA approvalSolubiomix LLC

    Sponsor: WATSON LABS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 22, 2026approval203d agoTEMOZOLOMIDE — FDA approvalAreva Pharmaceuticals Inc

    Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 22, 2026approval203d agoTEMOZOLOMIDE — FDA approvalAreva Pharmaceuticals Inc

    Sponsor: SUN PHARM. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 22, 2026approval203d agoACYCLOVIR — FDA approvalACYCLOVIR

    Sponsor: APOTEX. Form: CAPSULE. Route: ORAL

    full page →ACYCLOVIR →fda approvals ↗
    ›Jan 22, 2026approval203d agoAMLODIPINE BESYLATE — FDA approvalChina Resources Saike Pharmaceutical Co Ltd

    Sponsor: TEVA PHARMS INC. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Jan 22, 2026approval203d agoMETHADONE HYDROCHLORIDE — FDA approvalMETHADONE HYDROCHLORIDE

    Sponsor: VISTAPHARM LLC. Form: SOLUTION. Route: ORAL

    full page →METHADONE HYDROCHLORIDE →fda approvals ↗
    ›Jan 22, 2026approval203d agoOSELTAMIVIR PHOSPHATE — FDA approvalF. Hoffmann-La Roche Ltd

    Sponsor: UPSHER SMITH LABS. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Jan 22, 2026approval203d agoZILBRYSQ (ZILUCOPLAN SODIUM) — FDA approvalzilucoplan

    Sponsor: UCB INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →zilucoplan →fda approvals ↗
    ← prev
    page 10 of 201
    next →
    $MMSI91.11+1.52%
    $KVUE18.91+0.34%
    $VYCO0.06600.00%
    $TEVA36.48+0.94%
    $BSX51.19+1.45%
    $KVUE18.91+0.34%
    $STAA24.94-0.72%
    $VTRS16.280.00%
    $TEVA36.48+0.94%
    $SYK348.15+0.68%